Published in Am J Ind Med on January 01, 1989
Ingestion, inhalation, and dermal exposures to chloroform and trichloroethene from tap water. Environ Health Perspect (1996) 1.61
Breath measurements as volatile organic compound biomarkers. Environ Health Perspect (1996) 1.20
Blood and breath levels of selected volatile organic compounds in healthy volunteers. Analyst (2013) 1.02
Children's exposure to volatile organic compounds as determined by longitudinal measurements in blood. Environ Health Perspect (2005) 0.95
Benzene toxicokinetics in humans: exposure of bone marrow to metabolites. Occup Environ Med (1994) 0.85
The use of biomonitoring data in exposure and human health risk assessment: benzene case study. Crit Rev Toxicol (2013) 0.83
Biomarkers of environmental benzene exposure. Environ Health Perspect (1996) 0.79
Comparison of breath, blood and urine concentrations in the biomonitoring of environmental exposure to 1,3-butadiene, 2,5-dimethylfuran, and benzene. Int Arch Occup Environ Health (2003) 0.77
Infrequent normal B lymphocytes express features of B-chronic lymphocytic leukemia. J Exp Med (1982) 3.25
Immunoreactivity for thyroid transcription factor-1 in stage I non-small cell carcinomas of the lung. Am J Surg Pathol (2001) 2.42
A multicenter study of treatment of primary CNS lymphoma. Neurology (2002) 2.04
Receptor expression and responsiveness of human dendritic cells to a defined set of CC and CXC chemokines. J Immunol (1997) 2.02
Hydrocarbon exposure and Parkinson's disease. Neurology (2000) 1.70
Independent prognostic value of fascin immunoreactivity in stage I nonsmall cell lung cancer. Br J Cancer (2003) 1.55
Heterogeneous immunophenotype of granular lymphocyte expansions: differential expression of the CD8 alpha and CD8 beta chains. Blood (1992) 1.45
The susceptibility of low-density lipoprotein to in vitro oxidation is increased in hypercholesterolemic patients. Nutrition (1995) 1.41
Serum levels of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in treated patients with chronic myelogenous leukemia in chronic phase. Haematologica (2004) 1.40
In situ staining of bromodeoxyuridine positive cells in normal and neoplastic colony-forming units grown on plasma clots. J Immunol Methods (1988) 1.38
Prognostic relevance of tumour-cell growth fraction in malignant non-Hodgkin's lymphomas. Lancet (1987) 1.34
Partition coefficients of some industrial aliphatic hydrocarbons (C5-C7) in blood and human tissues. Br J Ind Med (1985) 1.32
Environmental and occupational exposure to benzene by analysis of breath and blood. Br J Ind Med (1988) 1.31
Nonsecretory multiple myeloma. Presenting findings, clinical course and prognosis. Acta Haematol (1985) 1.30
Normal equivalent cells of B cell malignancies: analysis with monoclonal antibodies. Br J Haematol (1983) 1.29
Stage-modified international prognostic index effectively predicts clinical outcome of localized primary gastric diffuse large B-cell lymphoma. International Extranodal Lymphoma Study Group (IELSG) Ann Oncol (1999) 1.24
Solvent exposure in a shoe upper factory. Int Arch Occup Environ Health (1978) 1.16
Carrier-dependent and Ca(2+)-dependent 5-HT and dopamine release induced by (+)-amphetamine, 3,4-methylendioxymethamphetamine, p-chloroamphetamine and (+)-fenfluramine. Br J Pharmacol (1997) 1.15
Urinary excretion of the metabolites of n-hexane and its isomers during occupational exposure. Br J Ind Med (1981) 1.15
Effective in vivo induction of NKG2D ligands in acute myeloid leukaemias by all-trans-retinoic acid or sodium valproate. Leukemia (2009) 1.14
Predictors of survival and toxicity in patients on adjuvant therapy with 5-fluorouracil for colorectal cancer. Br J Cancer (2009) 1.13
Randomized trial with or without granulocyte colony-stimulating factor as adjunct to induction VNCOP-B treatment of elderly high-grade non-Hodgkin's lymphoma. Blood (1997) 1.13
Area under the curve of methotrexate and creatinine clearance are outcome-determining factors in primary CNS lymphomas. Br J Cancer (2004) 1.13
Primary mediastinal large B-cell lymphoma (PMLBCL): long-term results from a retrospective multicentre Italian experience in 138 patients treated with CHOP or MACOP-B/VACOP-B. Br J Cancer (2004) 1.11
Urinary excretion of n-hexane metabolites in rats and humans. Int Arch Occup Environ Health (1979) 1.10
Primary mediastinal large B-cell lymphoma with sclerosis: a clinical study of 89 patients treated with MACOP-B chemotherapy and radiation therapy. Haematologica (2001) 1.08
The role of iron status markers in predicting response to intravenous iron in haemodialysis patients on maintenance erythropoietin. Nephrol Dial Transplant (2001) 1.08
The new TNM classification of lymph node metastasis minimises stage migration problems in gastric cancer patients. Br J Cancer (2002) 1.07
Normal and neoplastic plasma cell membrane phenotype: studies with new monoclonal antibodies. Clin Exp Immunol (1987) 1.06
Toluene concentrations in the blood and alveolar air of workers during the workshift and the morning after. Br J Ind Med (1986) 1.03
Biomonitoring of industrial solvent exposures in workers' alveolar air. Int Arch Occup Environ Health (1980) 1.02
Seizure susceptibility and epileptogenesis are decreased in transgenic rats overexpressing neuropeptide Y. Neuroscience (2002) 1.00
Detection of the neural cell adhesion molecule (NCAM) in serum of patients with small-cell lung cancer (SCLC) with "limited" or "extensive" disease, and bone-marrow infiltration. Int J Cancer Suppl (1994) 1.00
Methyl ethyl ketone exposure in industrial workers. Uptake and kinetics. Int Arch Occup Environ Health (1984) 0.99
A comparative analysis of three different techniques for the detection of breast cancer cells in bone marrow. Cancer (1991) 0.99
Alveolar air and blood dichloromethane concentration in shoe sole factory workers. Int Arch Occup Environ Health (1977) 0.99
Reference values for blood benzene in the occupationally unexposed general population. Int Arch Occup Environ Health (1992) 0.99
Histiocytic necrotizing lymphadenitis without granulocytic infiltration (Kikuchi's lymphadenitis). Morphological and immunohistochemical study of eight cases. Histopathology (1987) 0.98
Pattern of recurrence after surgery in adenocarcinoma of the gastro-oesophageal junction. Eur J Surg Oncol (2003) 0.98
Identification of the metabolites of n-hexane, cyclohexane, and their isomers in men's urine. Toxicol Appl Pharmacol (1980) 0.97
Application of high performance liquid chromatography/tandem mass spectrometry in the environmental and biological monitoring of health care personnel occupationally exposed to cyclophosphamide and ifosfamide. Rapid Commun Mass Spectrom (1998) 0.97
Phorbol ester induces abnormal chronic lymphocytic leukemia cells to express features of hairy cell leukemia. Blood (1985) 0.96
Peritoneal cytology does not increase the prognostic information provided by TNM in gastric cancer. World J Surg (2006) 0.95
Membrane phenotype and functional behaviour of T lymphocytes in multiple myeloma: correlation with clinical stages of the disease. Clin Exp Immunol (1984) 0.95
Urinary excretion of n-hexane metabolites. A comparative study in rat, rabbit and monkey. Arch Toxicol (1982) 0.95
Epigenetic alteration: new insights moving from tissue to plasma - the example of PCDH10 promoter methylation in colorectal cancer. Br J Cancer (2013) 0.94
Lung uptake and metabolism of cyclohexane in shoe factory workers. Int Arch Occup Environ Health (1980) 0.94
Solvent exposure in a shoe upper factory. II. Methylcyclopentane, 2-methylpentane, and 3-methylpentane concentration in alveolar and in environmental air and in blood. Int Arch Occup Environ Health (1979) 0.94
Sleeve lobectomy for non-small cell lung cancer and carcinoids: results in 160 cases. Eur J Cardiothorac Surg (2002) 0.94
[2,5-hexanedione in biological monitoring of occupational exposure to n-hexane]. Med Lav (1985) 0.93
Post-transcriptional regulation of HSP70 expression following oxidative stress in SH-SY5Y cells: the potential involvement of the RNA-binding protein HuR. Curr Pharm Des (2008) 0.92
Treatment of elderly patients (> or =60 years) with newly diagnosed acute promyelocytic leukemia. Results of the Italian multicenter group GIMEMA with ATRA and idarubicin (AIDA) protocols. Leukemia (2003) 0.92
The Gene-Environment Interactions in Respiratory Diseases (GEIRD) Project. Int Arch Allergy Immunol (2010) 0.92
Experimental neurotoxicity and urinary metabolites of the C5-C7 aliphatic hydrocarbons used as glue solvents in shoe manufacture. Clin Toxicol (1981) 0.92
Prognostic variables and clinical staging in multiple myeloma. Blood (1989) 0.92
Renal failure in multiple myeloma. A study of the presenting findings, response to treatment and prognosis in 26 patients. Nouv Rev Fr Hematol (1986) 0.91
Laparoscopic splenectomy for hematological diseases. Surg Endosc (2002) 0.91
Measurement of the urinary metabolites of N-hexane, cyclohexane and their isomers by gas chromatography. Int Arch Occup Environ Health (1981) 0.90
Biomonitoring of occupational toluene exposure. Int Arch Occup Environ Health (1982) 0.90
IL4 production and increased CD30 expression by a unique CD8+ T-cell subset in B-cell chronic lymphocytic leukaemia. Br J Haematol (1999) 0.90
The validity of urinary metabolites as indicators of low exposures to toluene. Int Arch Occup Environ Health (1985) 0.90
In vitro bone marrow purging of multidrug-resistant cells with a mouse monoclonal antibody directed against Mr 170,000 glycoprotein and a saporin-conjugated anti-mouse antibody. Cancer Res (1990) 0.90
Essential mixed cryoglobulinemia, type II: a manifestation of a low-grade malignant lymphoma? Clinical-morphological study of 12 cases with special reference to immunohistochemical findings in liver frozen sections. Acta Haematol (1988) 0.90
Elderly aggressive-histology non-Hodgkin's lymphoma: first-line VNCOP-B regimen experience on 350 patients. Blood (1999) 0.89
Immunohistochemical determination of growth fractions in human permanent cell lines and lymphoid tumours: a critical comparison of the monoclonal antibodies OKT9 and Ki-67. Br J Haematol (1987) 0.89
Chronic treatment with desipramine facilitates its effect on extracellular noradrenaline in the rat hippocampus: studies on the role of presynaptic alpha2-adrenoceptors. Naunyn Schmiedebergs Arch Pharmacol (2001) 0.89
Physiologicomathematical model for studying human exposure to organic solvents: kinetics of blood/tissue n-hexane concentrations and of 2,5-hexanedione in urine. Br J Ind Med (1986) 0.88
Lineage relationship of chronic lymphocytic leukemia and hairy cell leukemia: studies with TPA. Leuk Res (1984) 0.88
[Sudden death caused by freon 22?]. Med Lav (1993) 0.88
Detection of platelet-associated antibodies by flow cytometry in hematological autoimmune disorders. Ann Hematol (1995) 0.88
Anaplastic large cell lymphoma: a clinicopathologic study of 53 patients. Leuk Lymphoma (1996) 0.88
Malignant histiocytosis (true histiocytic lymphoma) clinicopathological study of 25 cases. Histopathology (1985) 0.88
High-affinity monomeric 67-kD laminin receptors and prognosis in pancreatic endocrine tumours. J Pathol (1997) 0.88
Cardiovascular structural changes and calcium antagonist therapy in patients with hypertension. J Cardiovasc Pharmacol (1994) 0.87
Immunohistochemical detection of the multidrug transport protein P170 in human normal tissues and malignant lymphomas. Histopathology (1991) 0.87
Benzene in blood as a biomarker of low level occupational exposure. Sci Total Environ (1999) 0.86
[Gas chromatographic determination of 2,5-hexanedione in the urine]. Med Lav (1987) 0.86
Anaplastic large cell lymphoma Hodgkin's-like: a randomized trial of ABVD versus MACOP-B with and without radiation therapy. Blood (1998) 0.86
Growth in young children with chronic renal failure. Pediatr Nephrol (1989) 0.86
Renal tubular acidosis in a case of Shwachman's syndrome. Acta Paediatr Scand (1986) 0.86
Ber-H2 (anti-CD30)-saporin immunotoxin: a new tool for the treatment of Hodgkin's disease and CD30+ lymphoma: in vitro evaluation. Br J Haematol (1992) 0.86
Predisposition to LDL oxidation in patients with and without angiographically established coronary artery disease. Atherosclerosis (1993) 0.86
Improved outcome in young adults with de novo acute myeloid leukemia in first remission, undergoing an allogeneic bone marrow transplant. Bone Marrow Transplant (2007) 0.86
Comparison of old and new TNM systems for nodal staging in adenocarcinoma of the gastro-oesophageal junction. Br J Surg (2004) 0.86
Breath and blood levels of benzene, toluene, cumene and styrene in non-occupational exposure. Int Arch Occup Environ Health (1989) 0.86